Patent covers brilaroxazine use for treating Pulmonary Fibrosis-Similar patents have also been granted in key markets around the world ...

Tenax Therapeutics ( ($TENX) ) has released its Q3 earnings. Here is a breakdown of the information Tenax Therapeutics presented to its investors.

Data showed that the expression (activity) of the ABCA3 gene was lower in IPAH patients, while that of the SMAD9 gene was ...

Liberia’s journey toward sustainable development and economic independence has been closely linked to its performance on the ...

Adequate management of COPD is important because hospitalisation for an acute exacerbation of COPD (AECOPD) is associated ...

AstraZeneca's hopes of a big new indication for respiratory drug Fasenra in chronic obstructive pulmonary disease (COPD) have been dashed by a negative phase 3 trial. The RESOLUTE study of IL-5 ...

The Union government has directed states and Union territories to establish a robust public health response, including ...

Blue Cell Therapeutics, a biotech developing "off-the-shelf" allogeneic stem cell therapies for diseases where angiogenesis and nerve regeneration are beneficial, today announces the appointment of ...

Cereno Scientific , an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced the submission of the clinical ...

This research also helps explain why chronic inflammation—caused by smoking, pollution, or long-term infections—has long been ...

As Delhi’s air quality plunges to hazardous levels, doctors are raising alarm over the severe impact of toxic air on children ...

Air pollution poses a global threat to health. Harmful substances affect lungs, heart, brain, and immune systems. Long-term ...